# Powerus Corp: financial statements, quarterly

PUSA · Nasdaq · CIK 2009312 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pusa.md) · [Financials](/companies/pusa/financials.md) · [Filings](/companies/pusa/filings.md) · [Insiders](/companies/pusa/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pusa/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [439](/filings/0001493152-24-049927.md) | [602 d](/filings/0001641172-25-001168.md) | [1,554](/filings/0001641172-25-010834.md) | [649](/filings/0001493152-25-011966.md) | [437](/filings/0001493152-25-022592.md) | [659 d](/filings/0001493152-26-014320.md) | [1,328](/filings/0001493152-26-022421.md) | [602](/filings/0001493152-26-037874.md) | [337](/filings/0001493152-25-022592.md) | [697 d](/filings/0001493152-26-014320.md) | [1,469](/filings/0001493152-26-022421.md) | [708](/filings/0001493152-26-037874.md) |
| Operating income | $k | [(285)](/filings/0001493152-24-049927.md) | [(366) d](/filings/0001641172-25-001168.md) | [480](/filings/0001641172-25-010834.md) | [(94.8)](/filings/0001493152-25-011966.md) | [(280)](/filings/0001493152-25-022592.md) | [(288) d](/filings/0001493152-26-014320.md) | [353](/filings/0001493152-26-022421.md) | [(427)](/filings/0001493152-26-037874.md) | [(2,874)](/filings/0001493152-25-022592.md) | [(1,458) d](/filings/0001493152-26-014320.md) | [(1,459)](/filings/0001493152-26-022421.md) | [(763)](/filings/0001493152-26-037874.md) |
| Interest expense | $k | [7.6](/filings/0001493152-24-049927.md) | [8.6 d](/filings/0001641172-25-001168.md) | [10.2](/filings/0001641172-25-010834.md) | [6.3](/filings/0001493152-25-011966.md) | [5.1](/filings/0001493152-25-022592.md) | [4.0 d](/filings/0001493152-26-014320.md) | [4.5](/filings/0001641172-25-010834.md) | [0.0 d](/filings/0001493152-25-011966.md) | [0.0 d](/filings/0001493152-25-022592.md) | [0.0 d](/filings/0001493152-26-014320.md) | not reported | not reported |
| Income tax | $k | [(57.1)](/filings/0001493152-24-049927.md) | [(44.1) d](/filings/0001641172-25-001168.md) | [160](/filings/0001641172-25-010834.md) | [(22.1)](/filings/0001493152-25-011966.md) | [(71.7)](/filings/0001493152-25-022592.md) | [(45.2) d](/filings/0001493152-26-014320.md) | [144](/filings/0001493152-26-022421.md) | [(53.5)](/filings/0001493152-26-037874.md) | [(120)](/filings/0001493152-25-022592.md) | [(61.8) d](/filings/0001493152-26-014320.md) | [91.0](/filings/0001493152-26-022421.md) | [(76.0)](/filings/0001493152-26-037874.md) |
| Net income | $k | [(229)](/filings/0001493152-24-049927.md) | [(323) d](/filings/0001641172-25-001168.md) | [329](/filings/0001493152-25-011966.md) | [(69.1)](/filings/0001493152-25-011966.md) | [(206)](/filings/0001493152-25-022592.md) | [(238) d](/filings/0001493152-26-014320.md) | [266](/filings/0001493152-26-037874.md) | [(289)](/filings/0001493152-26-037874.md) | [(2,525)](/filings/0001493152-25-022592.md) | [(1,129) d](/filings/0001493152-26-014320.md) | [(1,260)](/filings/0001493152-26-037874.md) | [(39.3)](/filings/0001493152-26-037874.md) |
| Diluted EPS | $ per share | [(0.02)](/filings/0001493152-24-049927.md) | not reported | [0.03](/filings/0001641172-25-010834.md) | [(0.01)](/filings/0001493152-25-011966.md) | [(0.02)](/filings/0001493152-25-022592.md) | not reported | [0.02](/filings/0001493152-26-022421.md) | [(0.02)](/filings/0001493152-26-037874.md) | [(0.18)](/filings/0001493152-25-022592.md) | not reported | [(0.03)](/filings/0001493152-26-022421.md) | [(0.00)](/filings/0001493152-26-037874.md) |
| Basic EPS | $ per share | [(0.02)](/filings/0001493152-24-049927.md) | not reported | [0.03](/filings/0001641172-25-010834.md) | [(0.01)](/filings/0001493152-25-011966.md) | [(0.02)](/filings/0001493152-25-022592.md) | not reported | [0.02](/filings/0001493152-26-022421.md) | [(0.02)](/filings/0001493152-26-037874.md) | [(0.18)](/filings/0001493152-25-022592.md) | not reported | [(0.03)](/filings/0001493152-26-022421.md) | [(0.00)](/filings/0001493152-26-037874.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating, us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [0.6](/filings/0001641172-25-001168.md) | not reported | not reported | [0.5](/filings/0001493152-24-049927.md) | [0.5](/filings/0001493152-26-014320.md) | [8.3](/filings/0001641172-25-010834.md) | [7.6](/filings/0001493152-25-011966.md) | [29.4](/filings/0001493152-25-022592.md) | [28.7](/filings/0001493152-26-037874.md) | [17.5](/filings/0001493152-26-022421.md) | [22.2](/filings/0001493152-26-037874.md) |
| Current assets | $m | not reported | [1.0](/filings/0001641172-25-001168.md) | not reported | not reported | [1.2](/filings/0001493152-24-049927.md) | [1.1](/filings/0001493152-26-014320.md) | [8.7](/filings/0001641172-25-010834.md) | [7.9](/filings/0001493152-25-011966.md) | [30.0](/filings/0001493152-25-022592.md) | [29.1](/filings/0001493152-26-037874.md) | [38.0](/filings/0001493152-26-022421.md) | [43.1](/filings/0001493152-26-037874.md) |
| Total assets | $m | not reported | [4.7](/filings/0001641172-25-001168.md) | not reported | not reported | [5.4](/filings/0001493152-24-049927.md) | [5.2](/filings/0001493152-26-014320.md) | [12.8](/filings/0001641172-25-010834.md) | [12.7](/filings/0001493152-25-011966.md) | [35.2](/filings/0001493152-25-022592.md) | [34.8](/filings/0001493152-26-037874.md) | [43.1](/filings/0001493152-26-022421.md) | [48.1](/filings/0001493152-26-037874.md) |
| Current liabilities | $m | not reported | [2.7](/filings/0001641172-25-001168.md) | not reported | not reported | [3.2](/filings/0001493152-24-049927.md) | [3.4](/filings/0001493152-26-014320.md) | [0.9](/filings/0001641172-25-010834.md) | [1.2](/filings/0001493152-25-011966.md) | [0.8](/filings/0001493152-25-022592.md) | [1.3](/filings/0001493152-26-037874.md) | [0.9](/filings/0001493152-26-022421.md) | [0.8](/filings/0001493152-26-037874.md) |
| Total liabilities | $m | not reported | [3.5](/filings/0001641172-25-001168.md) | not reported | not reported | [4.1](/filings/0001493152-24-049927.md) | [4.1](/filings/0001493152-26-014320.md) | [1.5](/filings/0001641172-25-010834.md) | [1.7](/filings/0001493152-25-011966.md) | [1.4](/filings/0001493152-25-022592.md) | [2.0](/filings/0001493152-26-037874.md) | [1.5](/filings/0001493152-26-022421.md) | [1.5](/filings/0001493152-26-037874.md) |
| Long-term debt | $m | not reported | [0.8](/filings/0001641172-25-001168.md) | not reported | not reported | [0.2](/filings/0001493152-24-049927.md) | [0.2](/filings/0001493152-26-014320.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | [0.1](/filings/0001641172-25-001168.md) | not reported | not reported | [0.1](/filings/0001493152-24-049927.md) | [0.1](/filings/0001493152-26-014320.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1.6](/filings/0001493152-24-049927.md) | [1.2](/filings/0001493152-26-014320.md) | [1.6](/filings/0001493152-25-011966.md) | [1.5](/filings/0001493152-25-022592.md) | [1.3](/filings/0001493152-25-022592.md) | [1.1](/filings/0001493152-26-037874.md) | [11.2](/filings/0001493152-26-037874.md) | [11.0](/filings/0001493152-26-037874.md) | [33.8](/filings/0001493152-25-022592.md) | [32.7](/filings/0001493152-26-037874.md) | [41.6](/filings/0001493152-26-037874.md) | [46.6](/filings/0001493152-26-037874.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(50.4) d](/filings/0001641172-25-001168.md) | [470](/filings/0001641172-25-010834.md) | [(75.6) d](/filings/0001493152-25-011966.md) | [(249) d](/filings/0001493152-25-022592.md) | [(55.9) d](/filings/0001493152-26-014320.md) | [(81.2)](/filings/0001493152-26-022421.md) | [(256) d](/filings/0001493152-26-037874.md) | [(1,161) d](/filings/0001493152-25-022592.md) | [(530) d](/filings/0001493152-26-014320.md) | [385](/filings/0001493152-26-022421.md) | [(293) d](/filings/0001493152-26-037874.md) |
| Capital expenditure | $k | [(35.8) d](/filings/0001641172-25-001168.md) | [99.9](/filings/0001641172-25-010834.md) | [8.7 d](/filings/0001493152-25-011966.md) | [18.1 d](/filings/0001493152-25-022592.md) | [(0.0) d](/filings/0001493152-26-014320.md) | [14.9](/filings/0001493152-26-022421.md) | [316 d](/filings/0001493152-26-037874.md) | [292 d](/filings/0001493152-25-022592.md) | [452 d](/filings/0001493152-26-014320.md) | [27.0](/filings/0001493152-26-022421.md) | [6.0 d](/filings/0001493152-26-037874.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [10.9](/filings/0001493152-24-049927.md) | [10.9](/filings/0001641172-25-010834.md) | [10.9](/filings/0001493152-25-011966.md) | [10.9](/filings/0001493152-25-022592.md) | [12.4](/filings/0001493152-26-022421.md) | [13.9](/filings/0001493152-26-037874.md) | [14.0](/filings/0001493152-25-022592.md) | [44.9](/filings/0001493152-26-022421.md) | [49.9](/filings/0001493152-26-037874.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 26,943,582 at 2026-08-13, from the cover of the [10-Q filed 2026-08-13](/filings/0001493152-26-037874.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.